Loading clinical trials...
Loading clinical trials...
This study aims to evaluate the performance and safety of the Orthoss® as a bone graft extender in lumbar spondylodesis involving 1-2 levels (L4-L5 and/or L5-S1).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Geistlich Pharma AG
NCT04992572 · Lumbar Spinal Stenosis
NCT05029726 · Lumbar Spinal Stenosis, Lumbar Disc Herniation, and more
NCT05058287 · Opioid Use, Lumbar Spinal Stenosis, and more
NCT05273879 · Lumbar Spinal Stenosis, Spinal Stenosis, and more
NCT04075539 · Symptomatic Lumbar Spinal Stenosis
Universitätsklinikum Augsburg - Neurochirurgische Klinik und Poliklinik
Augsburg
Universitätsklinikum Düsseldorf
Düsseldorf
Klinikum Magdeburg gGmbH
Magdeburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions